Under the leadership of Drs. Matthew Burns and Sub Subramony, the Fixel Institute receives recognition as an Ataxia Center of Excellence by the National Ataxia Foundation.
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
$744K in grants will support UF research projects and equipment.
Dr. Burns is tackling Parkinson’s from all angles - from patient care to cutting-edge research in neuroscience.
Insights could evolve concepts in understanding and treating Holmes Tremor.
